| SpectraBase Spectrum ID |
5YzqZnbCyES |
| Name |
1,4-Di-(3-Bromobenzyl) 2-methylpiperazine |
| Classification |
Piperazine designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
436.014974716 u |
| Formula |
C19H22Br2N2 |
| InChI |
InChI=1S/C19H22Br2N2/c1-15-12-22(13-16-4-2-6-18(20)10-16)8-9-23(15)14-17-5-3-7-19(21)11-17/h2-7,10-11,15H,8-9,12-14H2,1H3 |
| InChIKey |
FXVZLEMEWKANER-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
438.207 g/mol |
| Nominal Mass |
436 u |
| Quality |
954 |
| Retention Index |
2832 |
| SMILES |
C1(N(CCN(C1)CC=1C=C(C=CC1)Br)CC=1C=C(C=CC1)Br)C |
| SPLASH |
splash10-0300-5890000000-0a25799edecea20154b0 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Piperazine,1,4-di-(3-Bromobenzyl) 2-methyl
1,4-bis(3-bromobenzyl)-2-methylpiperazine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_011218 |
